Journals / Türk Psikiyatri Dergisi / 2014 / Cilt: 25 - Sayı: 2

The Relationship Between the Duration of Drug Use and the Bipolar Disorder Patients’ Sociodemographic and Clinical Characteristics

Bipolar bozukluk hastalarının ilaç kullanım sürelerinin sosyodemografik ve hastalık özellikleri ile ilişkisi

Pages
94–105
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The major findings of this study was that many sociodemographic as well as clinical manifestations including, early onset (aged ≤18 years), unmarried, first episode of mania, those with disease not showing seasonal features, psychotic symptoms, history of hospitalization, and higher number of manic or hypomanic episodes resulted in increased patient prescribed antipsychotic drugs Conclusion: Our data suggests that antipsychotic drugs are being used more frequently and for longer durations in the treatment of BD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study was to determine the duration of psychotropic drug use in the long-term follow-up of bipolar disorder (BD) patients.
📊
Key Findings & Data:The overarching goal for this study was to produce results that enlighten the development of new treatment strategies.
💡
Conclusion & Impact:The major findings of this study was that many sociodemographic as well as clinical manifestations including, early onset (aged ≤18 years), unmarried, first episode of mania, those with disease not showing seasonal features, psychotic symptoms, history of hospitalization, and higher number of manic or hypomanic episodes resulted in increased patient prescribed antipsychotic drugs Conclusion: Our data suggests that antipsychotic drugs are being used more frequently and for longer durations in the treatment of BD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study was to determine the duration of psychotropic drug use in the long-term follow-up of bipolar disorder (BD) patients. In addition, this study aimed to investigate their role in the daily clinical practice in association with patient sociodemographic and clinical characteristics. The overarching goal for this study was to produce results that enlighten the development of new treatment strategies. Method: Follow-up data acquired from the Psychiatry Department of Uludag University Faculty of Medicine was used to retrospectively evaluate 151 patients diagnosed with BD. Socio-demographic data of the patients andwere analyzed. information regarding the disease and the drugs used Results: Of the patients studied, 57.0% were female with a mean age of 41.5±12.8. The mean duration of follow-up was 1985.3±1933 [median 1291 (15-9135)] days; euthymic period accounted for 86.0% of this duration. Interestingly, incompliance with the treatment triggered the switch to mania and ineffective treatment triggered the switch to depression. Medication distribution was as follows: 95.4% of the patients received antipsychotic and mood stabilizer treatments, 3.3% received only mood stabilizer treatment, and 1.30% received only antipsychotic treatment. The major findings of this study was that many sociodemographic as well as clinical manifestations including, early onset (aged ≤18 years), unmarried, first episode of mania, those with disease not showing seasonal features, psychotic symptoms, history of hospitalization, and higher number of manic or hypomanic episodes resulted in increased patient prescribed antipsychotic drugs Conclusion: Our data suggests that antipsychotic drugs are being used more frequently and for longer durations in the treatment of BD.

Özet

Amaç: Bipolar bozukluk (BB) hastalarının uzun süreli takibinde, psikot- rop ilaç kullanım sürelerinin geriye dönük olarak belirlenmesi ve gün- lük klinik uygulamadaki yerinin hastaların sosyodemografik ve hastalık özellikleriyle ilişkilendirerek araştırılması amaçlanmıştır. Bu çalışmadan elde edilecek sonuçların yeni tedavi yöntemlerinin geliştirilmesine ışık tutacağı düşünülmektedir. Yöntem: Uludağ Üniversitesi Tıp Fakültesi, Ruh Sağlığı ve Hastalıkları Anabilim Dalı, Duygudurum Polikliniği tarafından BB tanısı ile izlenen 151 hastanın dosyası geriye dönük olarak incelendi. Hastaların sosyo- demografik ve hastalığa ait özellikleri ve kullandıkları ilaçların süreleri ilişkilendirildi. Bulgular: Hastaların ortalama yaşları 41,5±12,8 yıl olup %57’si ka- dındı. Tarafımızca izlem süresi ortalama 1985, 3±1933 [ortanca 1291 (15–9135)] gün olan hastaların bu sürenin %86’sını ötimik olarak geçirdikleri, tedaviye uyumsuz olmaları durumunda manik, tedavinin etkili olmaması durumunda ise depresif sürecin tetiklendiği belirlendi. Hastaların %95,4’ünün antipsikotik (AP) ve duygudurum düzenleyici (DDD), %3,3’ünün sadece DDD, %1,3’ünün ise yalnızca AP tedavi kullanmış olduğu saptandı. Çalışmamızın başlıca bulgusu; erken baş- langıçlı (≤18 yaş), evlenmemiş, ilk hastalık dönemi mani olan, hastalığı mevsimsel özellik göstermeyen, psikotik belirtileri bulunan, hastaneye yatış öyküsü olan, mani ve hipomani dönemleri çoğunluktaki hastaların daha fazla süre AP ilaç kullanımının olduğu yönündedir. Sonuç: BB uzun dönem tedavisinde AP ilaçların kullanımının sıklaştığı ve kullanım sürelerinin arttığı kanaatine varılmıştır.

🔖

Cite This Article

AKKAYA, C., DENİZ, G., KIRLI, S., CANGÜR, Ş. (2014). The Relationship Between the Duration of Drug Use and the Bipolar Disorder Patients’ Sociodemographic and Clinical Characteristics. Türk Psikiyatri Dergisi, Cilt: 25 - Sayı: 2, 94–105. https://ajindex.com/articles/88582

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akiskal HS (2007) Duygurum Bozuklukları: Klinik Özellikler. Comprehensive Textbook of Psychiatry, 8. baskı, cilt 2, BJ Sadock, VA Sadock (Ed) (Çev. H Aydın, A Bozkurt), Güneş Kitabevi, Ankara, s. 1611-52.
  2. Akkaya C, Altin M, Kora K ve ark. (2012) Sociodemographic and clinical features of patients with bipolar I disorder in Turkey-HOME study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 22:31- 42. Altınbas K, Smith D, Oral ET (2011) Adherence To Turkish Psychiatric Association Guideline for Bipolar Depression Treatment in a Specialized Mood Disorders Outpatient Unit. Psychıatrıa Danubına 23:189-93.
  3. Amerikan Psikiyatri Birliği (2001) Mental Bozuklukların Tanısal ve Sayımsal El Kitabı, Dördüncü Baskı (DSM-IV-TR) (Çev. ed.: E Köroğlu) Hekimler Yayın Birliği, Ankara, 2001.
  4. Amsterdam JD, Shults J (2005) Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression-lack of manic induction. J Affect Disorders 87:121-30.
  5. Angst J, Gamma A, Neuenschwander M ve ark. (2005) Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study. Epidemiol Psichiatr Soc 14:68-76.
  6. Angst J, Sellaro R (2000) Historical perspectives and natural history of bipolar disorder. Biol Psychiat 48:445-57.
  7. Baldessarini RJ, Tondo L (2008) Lithium and suicidal risk. Bipolar Disord 10: 114-5.
  8. Ballenger JC, Post RM (1980) Carbamazepine in manic depressive illness: a new treatment. Am J Psychiat 137:782-90.
  9. Bauer MS, Altshuler L, Evans DR ve ark. (2005) Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a mult-site public sector sample with bipolar disorder. J Affect Disorders 85:301-15.
  10. Biederman J, Mick E, Faraone SV ve ark. (2000) Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiat 48:458-66.
  11. Blanco C, Laje G, Olfson M ve ark. (2002) Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiat 159:1005-10.
  12. Boylan KR, Bieling PJ, Marriott M ve ark. (2004) Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiat 65:1106-13.
  13. Bozkurt A, Karlıdere T (2006) Bipolar bozukluğun tedavi ilkeleri. Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi 2:30-6.
  14. Braun KL, Nichols R (1997) Death and dying in four Asian American cultures: a descriptive study. Death Stud 21:327-59.
  15. Calabrese JR, Bowden CL, Sachs G ve ark. (2003) A placebo-controlled